產(chǎn)品詳情
簡單介紹：
Anti-Insulin receptor subunit beta抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-Insulin receptor subunit beta抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-Insulin receptor subunit beta
Cat. Number:
Anti-Insulin receptor subunit beta抗體KL-4995R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The human insulin receptor is a heterotetrameric membrane glycoprotein consisting of disulfide linked subunits in a beta-alpha-alpha-beta configuration. The beta subunit (95 kDa) possesses a single transmembrane domain, Anti-Insulin receptor subunit beta抗體whereas the alpha subunit (135 kDa) is completely extracellular. The insulin receptor exhibits receptor tyrosine kinase (RTK) activity. RTKs are single pass transmembrane receptors that possess intrinsic cytoplasmic enzymatic activity, catalyzing the transfer of the gamma phosphate of ATP to tyrosine residues in protein substrates. RTKs are essential components of signal transduction pathways that affect cell proliferation, differentiation, migration and metabolism.
Included in this large protein family are the insulin receptor and the receptors for growth factors such as epidermal growth factor, fibroblast growth factor and vascular endothelial growth factor. Receptor activation occurs through ligand binding, which facilitates receptor dimerization and autophosphorylation of specific tyrosine residues in the cytoplasmic portion. The interaction of insulin with the alpha subunit of the insulinAnti-Insulin receptor subunit beta抗體 receptor activates the protein tyrosine kinase of the beta subunit, which then undergoes an autophosphorylation that increases its tyrosine kinase activity. Three adapter proteins, IRS1, IRS2 and Shc, become phosphorylated on tyrosine residues following insulin receptor activation. These three phosphorylated proteins then interact with SH2 domain containing signaling proteins.
Included in this large protein family are the insulin receptor and the receptors for growth factors such as epidermal growth factor, fibroblast growth factor and vascular endothelial growth factor. Receptor activation occurs through ligand binding, which facilitates receptor dimerization and autophosphorylation of specific tyrosine residues in the cytoplasmic portion. The interaction of insulin with the alpha subunit of the insulinAnti-Insulin receptor subunit beta抗體 receptor activates the protein tyrosine kinase of the beta subunit, which then undergoes an autophosphorylation that increases its tyrosine kinase activity. Three adapter proteins, IRS1, IRS2 and Shc, become phosphorylated on tyrosine residues following insulin receptor activation. These three phosphorylated proteins then interact with SH2 domain containing signaling proteins.
Also known as:
CD 220; CD220; CD220 antigen; HHF 5; HHF5; HIR B; INSR; INSR; Insulin receptor; Insulin receptor subunit beta; IR; INSR_HUMAN.Anti-Insulin receptor subunit beta抗體
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Insulin .
●
Predicted Molecular Weight: 68kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:20-540 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-Insulin receptor subunit beta抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-Insulin receptor subunit beta抗體
Optimal working dilutions must be determined by the end user.
kl645Hu01 晚期糖基化終末產(chǎn)物受體(AGER)多克隆抗體 Polyclonal Antibody to Advanced Glycosylation End Product Specific Receptor (AGER)
kl645Mu01 晚期糖基化終末產(chǎn)物受體(AGER)多克隆抗體 Polyclonal Antibody to Advanced Glycosylation End Product Specific Receptor (AGER)
kl646Hu01 骨形成蛋白6(BMP6)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
kl646Mu01 骨形成蛋白6(BMP6)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
kl646Ra01 骨形成蛋白6(BMP6)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
kl647Hu01 Smad同源物1(Smad1)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 1 (Smad1)
kl647Ra01 Smad同源物1(Smad1)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 1 (Smad1)
kl648Hu01 Smad同源物7(Smad7)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 7 (Smad7)
kl648Mu01 Smad同源物7(Smad7)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 7 (Smad7)
kl648Ra01 Smad同源物7(Smad7)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 7 (Smad7)
kl651Hu01 透明質(zhì)酸結(jié)合蛋白1(HABP1)多克隆抗體 Polyclonal Antibody to Hyaluronan Binding Protein 1 (HABP1)
kl651Mu01 透明質(zhì)酸結(jié)合蛋白1(HABP1)多克隆抗體 Polyclonal Antibody to Hyaluronan Binding Protein 1 (HABP1)
kl651Ra01 透明質(zhì)酸結(jié)合蛋白1(HABP1)多克隆抗體 Polyclonal Antibody to Hyaluronan Binding Protein 1 (HABP1)
kl653Hu01 骨形成蛋白1(BMP1)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 1 (BMP1)
kl653Mu01 骨形成蛋白1(BMP1)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 1 (BMP1)
kl653Ra01 骨形成蛋白1(BMP1)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 1 (BMP1)
kl655Ra01 鈣/鈣調(diào)蛋白依賴性蛋白激酶Ⅱγ(CAMK2γ)多克隆抗體 Polyclonal Antibody to Calcium/Calmodulin Dependent Protein Kinase II Gamma (CAMK2g)
